Vigabatrin Tablet — FDA Drug Shortage

To Be Discontinued — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Vigabatrin Tablet (tablet) from Hikma Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on Oct 16, 2026.

Shortage details

Status
To Be Discontinued
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0054-0652-25
Dosage Form
Tablet
Presentation
Vigabatrin, Tablet, 500 mg (NDC 0054-0652-25)
Initial Posting
Oct 16, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.